日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies

PULSAR 和 STELLAR 研究的汇总分析显示,激活素信号抑制剂 sotatercept 具有疗效和安全性。

Hoeper, Marius M; Gomberg-Maitland, Mardi; Badesch, David B; Gibbs, J Simon R; Grünig, Ekkehard; Kopeć, Grzegorz; McLaughlin, Vallerie V; Meyer, Gisela; Olsson, Karen M; Preston, Ioana R; Rosenkranz, Stephan; Souza, Rogerio; Waxman, Aaron B; Perchenet, Loïc; Strait, James; Xing, Aiwen; Manimaran, Solaiappan; Wang, Xuelong; Miller, Barry; Cornell, Alexandra G; de Oliveira Pena, Janethe; Ghofrani, H Ardeschir; Humbert, Marc

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension

索他西普治疗肺动脉高压:PULSAR开放标签扩展研究

Humbert, Marc; McLaughlin, Vallerie; Gibbs, J Simon R; Gomberg-Maitland, Mardi; Hoeper, Marius M; Preston, Ioana R; Souza, Rogerio; Waxman, Aaron B; Ghofrani, Hossein-Ardeschir; Escribano Subias, Pilar; Feldman, Jeremy; Meyer, Gisela; Montani, David; Olsson, Karen M; Manimaran, Solaiappan; de Oliveira Pena, Janethe; Badesch, David B

Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial

索他西普对血液动力学和右心功能的影响:STELLAR试验分析

Souza, Rogerio; Badesch, David B; Ghofrani, H Ardeschir; Gibbs, J Simon R; Gomberg-Maitland, Mardi; McLaughlin, Vallerie V; Preston, Ioana R; Waxman, Aaron B; Grünig, Ekkehard; Kopeć, Grzegorz; Meyer, Gisela; Olsson, Karen M; Rosenkranz, Stephan; Lin, Jianxin; Johnson-Levonas, Amy O; de Oliveira Pena, Janethe; Humbert, Marc; Hoeper, Marius M

Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry

COVID-19 大流行对肺动脉高压患者慢性病管理和患者报告结局的影响:肺动脉高压协会注册研究

Mayer, Megan; Badesch, David B; Nielsen, Kelly H; Kawut, Steven; Bull, Todd; Ryan, John J; Sager, Jeffrey; Mazimba, Sula; Hemnes, Anna; Klinger, James; Runo, James; McConnell, John W; De Marco, Teresa; Chakinala, Murali M; Yung, Delphine; Elwing, Jean; Kaplan, Adolfo; Argula, Rahul; Pomponio, Raymond; Peterson, Ryan; Hountras, Peter

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry

现代肺动脉高压患者的死亡率:来自肺动脉高压协会注册研究的早期见解

Chang, Kevin Y; Duval, Sue; Badesch, David B; Bull, Todd M; Chakinala, Murali M; De Marco, Teresa; Frantz, Robert P; Hemnes, Anna; Mathai, Stephen C; Rosenzweig, Erika Berman; Ryan, John J; Thenappan, Thenappan

Inference following multiple imputation for generalized additive models: an investigation of the median p-value rule with applications to the Pulmonary Hypertension Association Registry and Colorado COVID-19 hospitalization data

多重插补后广义加性模型的推断:以肺动脉高压协会注册数据和科罗拉多州 COVID-19 住院数据为例,探讨中位数 p 值规则

Bolt, Matthew A; MaWhinney, Samantha; Pattee, Jack W; Erlandson, Kristine M; Badesch, David B; Peterson, Ryan A

Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer

肺动脉高压的替代标志物或可为肺癌预后提供信息

Forbes, Lindsay M; Gu, Sue; Badesch, David B

United States Pulmonary Hypertension Scientific Registry: Baseline Characteristics

美国肺动脉高压科学注册研究:基线特征

Badlam, Jessica B; Badesch, David B; Austin, Eric D; Benza, Raymond L; Chung, Wendy K; Farber, Harrison W; Feldkircher, Kathy; Frost, Adaani E; Poms, Abby D; Lutz, Katie A; Pauciulo, Michael W; Yu, Chang; Nichols, William C; Elliott, C Gregory

Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry

肺动脉高压协会注册研究中甲基苯丙胺相关性肺动脉高压与特发性肺动脉高压的临床差异和结局

Kolaitis, Nicholas A; Zamanian, Roham T; de Jesus Perez, Vinicio A; Badesch, David B; Benza, Raymond L; Burger, Charles D; Chakinala, Murali M; Elwing, Jean M; Feldman, Jeremy; Lammi, Matthew R; Mathai, Stephen C; McConnell, John W; Presberg, Kenneth W; Robinson, Jeffrey C; Sager, Jeffrey; Shlobin, Oksana A; Simon, Marc A; Kawut, Steven M; Glidden, David V; Singer, Jonathan P; De Marco, Teresa

Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry

基线和连续脑钠肽水平可预测肺动脉高压患者的5年总生存率:来自REVEAL注册研究的数据

Frantz, Robert P; Farber, Harrison W; Badesch, David B; Elliott, C Greg; Frost, Adaani E; McGoon, Michael D; Zhao, Carol; Mink, David R; Selej, Mona; Benza, Raymond L